Claveau et al.'s study showed that apremilast significantly reduces epidermal thickness and proliferation, decreases the histopathological appearance of psoriasis, and reduces expression of TNF-α, human leukocyte antigen-DR, and intercellular adhesion molecule-1 in lesioned skin [46]. This evidence concerns the gene TNF and psoriasis.